We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
MITOCIN (Echo Therapeutics Pty Ltd)
Product name
MITOCIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
125 (255 working days)
Active ingredients
Mitomycin
Registration type
New generic medicine
Indication
MITOMYCIN is indicated in the palliative treatment of carcinoma of the stomach, pancreas, colon, lung (non-small cell), breast, cervix, head and neck, liver and bladder.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine